Amgen

Amgen

Organization

Heard in 64 episodes across 21 shows since Nov 2025

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. It discovers, develops, manufactures, and delivers biologic medicines for serious diseases, using biology and technology to address major unmet medical needs.

Discussed inMarkets89%AI & Tech11%

Episodes

64
across 21 shows

This week

0
episodes on 0 shows

Expert statements

22
16 positive · 4 negative

Share of the conversation

Mentions of Amgen per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.05‰0.1‰0.15‰Aug 25Sep 16Oct 9Oct 31Nov 22
Show the data
DayShare (7-day)Mentions
Aug 270.01‰1
Sep 80.08‰7
Sep 90.09‰1
Sep 120.11‰2
Sep 130.12‰1
Sep 140.12‰1
Sep 280.02‰2
Oct 10.03‰1
Oct 70.02‰1
Oct 220.02‰3
Oct 230.03‰1
Oct 260.07‰4
Oct 270.07‰1
Oct 280.08‰1
Oct 300.07‰2
Oct 310.08‰1
Nov 30.04‰1
Nov 40.07‰4
Nov 60.06‰1
Nov 110.02‰2
Nov 200.01‰1

The full trend: rank, tone and why it is trending →

Email alert

Email me when Amgen comes up on a podcast

One email a week at most, with the new episodes that mention Amgen. Free, no account needed, unsubscribe in one click.

What experts have said about Amgen

22 statements · 16 positive · 4 negative · 1 mixed · 1 neutral

  1. Yaron WerberPositiveNov 6, 2026· Biotech Hangout

    Amgen’s phase three Sjögren’s trial produced very strong results.

    “Amgen sort of hit it out of the ballpark in the phase three”

    Listen at 55:00

    Open the episode · Episode 202 - November 6, 2026
  2. Yaron WerberPositiveNov 6, 2026· Biotech Hangout

    Amgen will probably file its obesity pen application in the second half of next year if successful.

    “they're probably going to be filing assuming success in the second half of next year with the pen.”

    Listen at 55:58

    Open the episode · Episode 202 - November 6, 2026
  3. Karen FinermanPositiveNov 4, 2026· CNBC's "Fast Money"

    Amgen is a value investment yielding approximately 6%.

    “this is a value play that pays you 6%”

    Listen at 20:12

    Open the episode · Cracks In The AI Trade… And AMD Reports Results 11/3/26

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

64 episodes featuring Amgen, newest first